Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
CHEMBL1893324 207316 20 None 1 3 Human 10.7 pEC50 = 10.7 Functional
Agonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAgonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1021/acs.jmedchem.0c01396
168299476 192144 0 None -1 3 Human 10.5 pEC50 = 10.5 Functional
Agonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAgonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4660 165 74 67 -19.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1021/acs.jmedchem.0c01396
CHEMBL5220770 192144 0 None -1 3 Human 10.5 pEC50 = 10.5 Functional
Agonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAgonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4660 165 74 67 -19.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1021/acs.jmedchem.0c01396
CHEMBL4294827 211784 0 None -2 2 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H]1CNC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NC(CC(N)=O)CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O nan
CHEMBL4280734 211661 0 None 223 2 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
2263 255 0 None -4 3 Human 9.2 pEC50 = 9.2 Functional
Activity at human VPAC1 receptor in CHO cells by measuring cAMP accumulationActivity at human VPAC1 receptor in CHO cells by measuring cAMP accumulation
ChEMBL None None None None 10.1021/jm0609059
44566111 255 0 None -4 3 Human 9.2 pEC50 = 9.2 Functional
Activity at human VPAC1 receptor in CHO cells by measuring cAMP accumulationActivity at human VPAC1 receptor in CHO cells by measuring cAMP accumulation
ChEMBL None None None None 10.1021/jm0609059
CHEMBL219499 255 0 None -4 3 Human 9.2 pEC50 = 9.2 Functional
Activity at human VPAC1 receptor in CHO cells by measuring cAMP accumulationActivity at human VPAC1 receptor in CHO cells by measuring cAMP accumulation
ChEMBL None None None None 10.1021/jm0609059
CHEMBL4295255 211787 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Induction of VIPR1 receptor internalization in CHOK1 cells expressing human VIPR1 by beta-galactosidase reporter gene assayInduction of VIPR1 receptor internalization in CHOK1 cells expressing human VIPR1 by beta-galactosidase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4282016 211680 0 None -204 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O nan
CHEMBL4277870 211633 0 None -1659 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4282364 211683 0 None -1071 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NC(CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NC(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4287451 211721 0 None -426 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NC(CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NC(CCC(N)=O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4295255 211787 0 None - 1 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4277441 211623 0 None -1202 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4286419 211715 0 None -234 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NC(CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4281814 211676 0 None 58 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4290756 211753 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H]1CCC[C@@H]1C(=O)NC(CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)Cc1ccc(O)cc1)[C@@H](C)O nan
CHEMBL4277709 211629 0 None 870 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4277799 211632 0 None -977 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4284839 211700 0 None 11 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CC(CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4281905 211678 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4291903 211763 0 None -660 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H]1CCC[C@@H]1C(=O)NC(CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NC(CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)CC(C)C)[C@@H](C)O)Cc1ccc(O)cc1)[C@@H](C)O nan
CHEMBL4282941 211686 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4294843 211785 0 None 11 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)NC(CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4291119 211758 0 None -22 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(CCCCN)CC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4277783 211631 0 None -1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CC(NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CC(CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4284961 211703 0 None -9 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1CNC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC(Cc1ccc(O)cc1)NC(=O)CC(CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O nan
57395756 70869 0 None - 1 Rat 7.0 pIC50 = 7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(Cl)c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956426 70869 0 None - 1 Rat 7.0 pIC50 = 7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(Cl)c2)c1CO 10.1016/j.bmcl.2012.01.082
57399212 70877 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccccc1CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956434 70877 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccccc1CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
11570626 2513 40 None -707 9 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
9135 2513 40 None -707 9 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
CHEMBL1933349 2513 40 None -707 9 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
DB12044 2513 40 None -707 9 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
168298339 192107 0 None -33 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAntagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4137 147 67 59 -16.2 CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](CCS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C 10.1021/acs.jmedchem.0c01396
CHEMBL5219662 192107 0 None -33 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAntagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4137 147 67 59 -16.2 CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](CCS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C 10.1021/acs.jmedchem.0c01396
57395755 70868 0 None - 1 Rat 6.9 pIC50 = 6.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc3ccccc3c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956425 70868 0 None - 1 Rat 6.9 pIC50 = 6.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc3ccccc3c2)c1CO 10.1016/j.bmcl.2012.01.082
19220887 70882 2 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 344 4 1 3 4.7 N#Cc1c(NC(=O)CCc2ccc(Cl)cc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956439 70882 2 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 344 4 1 3 4.7 N#Cc1c(NC(=O)CCc2ccc(Cl)cc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
810647 70871 44 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 234 2 1 3 2.8 CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956428 70871 44 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 234 2 1 3 2.8 CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
57402730 70886 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 336 2 1 3 4.2 N#Cc1c(NC(=O)C2CCc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956443 70886 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 336 2 1 3 4.2 N#Cc1c(NC(=O)C2CCc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57399163 70857 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956414 70857 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
290230 32394 35 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 220 1 1 3 2.5 CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1412798 32394 35 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 220 1 1 3 2.5 CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
290221 86824 31 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 2 1 3 3.8 N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL233000 86824 31 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 2 1 3 3.8 N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
684674 152021 22 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 3 3.7 N#Cc1c(NC(=O)Cc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL397167 152021 22 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 3 3.7 N#Cc1c(NC(=O)Cc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57402678 70856 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 328 4 1 2 6.0 CSc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956413 70856 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 328 4 1 2 6.0 CSc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
57399214 70887 0 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 322 2 1 3 3.9 N#Cc1c(NC(=O)C2Cc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956444 70887 0 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 322 2 1 3 3.9 N#Cc1c(NC(=O)C2Cc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57399211 70867 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2cccc3ccccc23)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956424 70867 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2cccc3ccccc23)c1CO 10.1016/j.bmcl.2012.01.082
57390453 70874 1 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 260 2 1 3 3.2 N#Cc1c(NC(=O)C2CCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956431 70874 1 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 260 2 1 3 3.2 N#Cc1c(NC(=O)C2CCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
800118 70872 5 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 262 3 1 3 3.5 CC(C)CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956429 70872 5 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 262 3 1 3 3.5 CC(C)CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
57395758 70883 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 352 3 1 4 4.9 N#Cc1c(NC(=O)Cc2cc3ccccc3s2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956440 70883 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 352 3 1 4 4.9 N#Cc1c(NC(=O)Cc2cc3ccccc3s2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57395679 70855 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956412 70855 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
57393989 70866 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(-c3ccccc3)c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956423 70866 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(-c3ccccc3)c2)c1CO 10.1016/j.bmcl.2012.01.082
57397531 70865 0 None - 1 Rat 6.6 pIC50 = 6.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956422 70865 0 None - 1 Rat 6.6 pIC50 = 6.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
694422 70873 26 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 246 2 1 3 2.8 N#Cc1c(NC(=O)C2CC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956430 70873 26 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 246 2 1 3 2.8 N#Cc1c(NC(=O)C2CC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57399210 70864 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(Cl)cc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956421 70864 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(Cl)cc2)c1CO 10.1016/j.bmcl.2012.01.082
767327 70876 31 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 4 1 3 4.1 N#Cc1c(NC(=O)CCc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956433 70876 31 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 4 1 3 4.1 N#Cc1c(NC(=O)CCc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57393988 70863 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956420 70863 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
57395754 70862 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 325 4 1 2 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(N(C)C)c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956419 70862 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 325 4 1 2 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(N(C)C)c2)c1CO 10.1016/j.bmcl.2012.01.082
57400888 70849 0 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956259 70849 0 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
729610 56141 12 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 248 2 1 3 3.1 CC(C)C(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1632048 56141 12 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 248 2 1 3 3.1 CC(C)C(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
57400972 70884 0 None - 1 Rat 5.4 pIC50 = 5.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 338 3 1 4 3.8 N#Cc1c(NC(=O)CC2Cc3ccccc3O2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956441 70884 0 None - 1 Rat 5.4 pIC50 = 5.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 338 3 1 4 3.8 N#Cc1c(NC(=O)CC2Cc3ccccc3O2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57397476 70861 0 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 3 1 1 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956418 70861 0 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 3 1 1 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
4625719 70881 12 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956438 70881 12 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
4578060 70875 10 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 274 2 1 3 3.6 N#Cc1c(NC(=O)C2CCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956432 70875 10 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 274 2 1 3 3.6 N#Cc1c(NC(=O)C2CCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
847353 151395 10 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 288 2 1 3 4.0 N#Cc1c(NC(=O)C2CCCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL396627 151395 10 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 288 2 1 3 4.0 N#Cc1c(NC(=O)C2CCCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
16644244 70879 7 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956436 70879 7 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
57393990 70885 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 335 3 2 3 4.2 N#Cc1c(NC(=O)Cc2cc3ccccc3[nH]2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956442 70885 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 335 3 2 3 4.2 N#Cc1c(NC(=O)Cc2cc3ccccc3[nH]2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57392239 70880 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956437 70880 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
57390395 70860 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(-c3ccccc3)cc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956417 70860 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(-c3ccccc3)cc2)c1CO 10.1016/j.bmcl.2012.01.082
15015051 70859 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 300 3 1 1 5.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(F)cc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956416 70859 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 300 3 1 1 5.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(F)cc2)c1CO 10.1016/j.bmcl.2012.01.082
57399213 70878 1 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956435 70878 1 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
57395757 70870 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 3 1 1 5.9 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1C 10.1016/j.bmcl.2012.01.082
CHEMBL1956427 70870 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 3 1 1 5.9 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1C 10.1016/j.bmcl.2012.01.082
57400906 70858 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccccc1-c1cc(C(C)(C)C)cc(C(C)C)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956415 70858 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccccc1-c1cc(C(C)(C)C)cc(C(C)C)c1CO 10.1016/j.bmcl.2012.01.082
775619 70888 16 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 4 3.5 N#Cc1c(NC(=O)COc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956445 70888 16 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 4 3.5 N#Cc1c(NC(=O)COc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
2258 2942 0 None -15 4 Human 7.4 pEC50 = 7.4 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2278 325 0 None 4168 3 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16133238 2941 0 None -44 6 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2257 2941 0 None -44 6 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
44134520 2941 0 None -44 6 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
1152 3932 13 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16129679 3932 13 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
53395115 3932 13 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
91898389 3932 13 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
CHEMBL1981592 3932 13 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
1152 3932 13 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16129679 3932 13 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
53395115 3932 13 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
91898389 3932 13 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
CHEMBL1981592 3932 13 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2278 325 0 None 4168 3 Human 10.2 pEC50 = 10.2 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2259 3294 0 None -190 4 Human 6.0 pEC50 = 6 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
129887154 576 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
155817438 576 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
16214732 576 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
2269 576 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
2281 576 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
2272 3029 0 None -30 3 Human 8.1 pEC50 = 8.1 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
1152 3932 13 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
16129679 3932 13 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
53395115 3932 13 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
91898389 3932 13 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
CHEMBL1981592 3932 13 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
2258 2942 0 None -15 4 Human 9.7 pEC50 = 9.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16133238 2941 0 None -44 6 Human 9.9 pEC50 = 9.9 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2257 2941 0 None -44 6 Human 9.9 pEC50 = 9.9 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
44134520 2941 0 None -44 6 Human 9.9 pEC50 = 9.9 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16133238 2941 0 None -44 6 Human 8.2 pEC50 = 8.2 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
2257 2941 0 None -44 6 Human 8.2 pEC50 = 8.2 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
44134520 2941 0 None -44 6 Human 8.2 pEC50 = 8.2 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
3842 2403 0 None -2 5 Human 8.3 pEC50 = 8.3 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
1152 3932 13 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16129679 3932 13 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
53395115 3932 13 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
91898389 3932 13 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
CHEMBL1981592 3932 13 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
1152 3932 13 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
16129679 3932 13 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
53395115 3932 13 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
91898389 3932 13 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
CHEMBL1981592 3932 13 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
2278 325 0 None 4168 3 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
1152 3932 13 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
16129679 3932 13 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
53395115 3932 13 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
91898389 3932 13 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
CHEMBL1981592 3932 13 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
2272 3029 0 None -30 3 Human 5.5 pEC50 > 5.5 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2276 3293 0 None -316 2 Human 6.0 pEC50 > 6 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
2259 3294 0 None -190 4 Human 6.0 pEC50 > 6 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
43708 215968 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 525 10 3 13 -0.7 CN(C)CCN1N=NN=C1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)CC1=CSC(N)=N1)C2=O)C(O)=O None
131850923 3028 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
155817437 3028 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
16154651 3028 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
2268 3028 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
131850923 3028 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
155817437 3028 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16154651 3028 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2268 3028 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
131850923 3028 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
155817437 3028 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16154651 3028 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2268 3028 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
CHEMBL524658 213838 0 None - 1 Human 10.4 pIC50 = 10.4 Binding
Displacement of [125I]PACAP1-27 from human recombinant PAC1 receptor expressed in CHO cells measured after 120 mins by scintillation counting methodDisplacement of [125I]PACAP1-27 from human recombinant PAC1 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.bmc.2016.11.014
CHEMBL524658 213838 0 None - 1 Human 10.3 pIC50 = 10.3 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.bmc.2013.03.016
CHEMBL1893324 207316 20 None - 1 Human 10.0 pIC50 = 10.0 Binding
Displacement of [125I]VIP from human recombinant VIP1 receptor expressed in CHO cellsDisplacement of [125I]VIP from human recombinant VIP1 receptor expressed in CHO cells
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.bmc.2016.03.006
CHEMBL3884667 210670 0 None - 0 Human 10.0 pIC50 = 10.0 Binding
Displacement of [125I]VIP from human recombinant VPAC1 receptor expressed in CHO cells measured after 60 mins by scintillation counting methodDisplacement of [125I]VIP from human recombinant VPAC1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.bmc.2016.11.014
CHEMBL1893324 207316 20 None - 1 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.bmc.2013.03.016
CHEMBL1893324 207316 20 None - 1 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.ejmech.2013.01.044
72548703 161019 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysisDisplacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
CHEMBL4128926 161019 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysisDisplacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
127034614 135980 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736230 135980 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
127034614 135980 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736230 135980 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
2263 255 0 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cellsDisplacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm0609059
44566111 255 0 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cellsDisplacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm0609059
CHEMBL219499 255 0 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cellsDisplacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm0609059
CHEMBL507480 212564 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL4296687 211793 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of human VIP1 receptorInhibition of human VIP1 receptor
ChEMBL None None None CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O 10.1021/jm701575k
CHEMBL524852 213845 4 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
127035881 135962 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736134 135962 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
127035881 135962 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736134 135962 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL1893324 207316 20 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.ejmech.2013.01.044
1155 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129665 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3643 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1201488 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
DB00021 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3842 2403 0 None - 0 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
1152 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129679 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
53395115 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
91898389 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1981592 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3293 465 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
1155 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129665 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3643 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1201488 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
DB00021 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3293 465 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
1152 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129679 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
53395115 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
91898389 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1981592 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3842 2403 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
129887154 576 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
155817438 576 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
16214732 576 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
2269 576 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
2281 576 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
2275 3064 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1155 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129665 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
3643 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1201488 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
DB00021 3516 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16132369 1887 0 None - 1 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2280 1887 0 None - 1 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53230038 1887 0 None - 1 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2273 3060 0 None - 0 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2259 3294 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
1155 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129665 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
3643 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1201488 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
DB00021 3516 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2272 3029 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11068102
2259 3294 0 None - 0 Human 7.0 pIC50 = 7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9145428
2266 2850 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
3842 2403 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16133238 2941 0 None 1 3 Human 7.8 pIC50 = 7.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
2257 2941 0 None 1 3 Human 7.8 pIC50 = 7.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
44134520 2941 0 None 1 3 Human 7.8 pIC50 = 7.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
131850923 3028 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
155817437 3028 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
16154651 3028 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
2268 3028 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
1152 3932 13 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16129679 3932 13 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
53395115 3932 13 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
91898389 3932 13 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
CHEMBL1981592 3932 13 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16132369 1887 0 None - 1 Rat 8.1 pIC50 = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2280 1887 0 None - 1 Rat 8.1 pIC50 = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53230038 1887 0 None - 1 Rat 8.1 pIC50 = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2271 2851 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16133238 2941 0 None 1 3 Human 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2257 2941 0 None 1 3 Human 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
44134520 2941 0 None 1 3 Human 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2273 3060 0 None - 0 Rat 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2275 3064 0 None - 0 Rat 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2271 2851 0 None - 0 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
1152 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
1152 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1152 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16129679 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16129679 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129679 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
53395115 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
53395115 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53395115 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
91898389 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
91898389 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
91898389 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
CHEMBL1981592 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
CHEMBL1981592 3932 13 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1981592 3932 13 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16133238 2941 0 None - 3 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2257 2941 0 None - 3 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
44134520 2941 0 None - 3 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1152 3932 13 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129679 3932 13 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53395115 3932 13 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
91898389 3932 13 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1981592 3932 13 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1152 3932 13 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
16129679 3932 13 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
53395115 3932 13 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
91898389 3932 13 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
CHEMBL1981592 3932 13 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
131850923 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
131850923 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
155817437 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
155817437 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
16154651 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
16154651 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
2268 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
2268 3028 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
2259 3294 0 None - 0 Human 6.0 pIC50 > 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
53314964 214570 0 125I-VIP 1 3 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 3325 113 51 48 -14.6 CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC=N4)N None
53314964 214570 0 125I-VIP 1 3 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 3325 113 51 48 -14.6 CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC=N4)N None
53314964 214570 0 125I-VIP 1 3 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 3325 113 51 48 -14.6 CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC=N4)N None
243 3153 85 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 3153 85 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 3153 85 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 3153 85 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 3153 85 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
1152 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
1152 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3932 13 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
1152 3932 13 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
16129679 3932 13 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
53395115 3932 13 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
91898389 3932 13 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
CHEMBL1981592 3932 13 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
2274 3062 0 None - 1 Human 5.7 pKi = 5.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16132353 1759 0 None - 1 Human 6.2 pKi = 6.2 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2270 1759 0 None - 1 Human 6.2 pKi = 6.2 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16132369 1887 0 None - 1 Human 7.3 pKi = 7.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2280 1887 0 None - 1 Human 7.3 pKi = 7.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
53230038 1887 0 None - 1 Human 7.3 pKi = 7.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2278 325 0 None 316 2 Human 8.1 pKi = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
2258 2942 0 None -2 3 Human 8.2 pKi = 8.2 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16133238 2941 0 None 1 3 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2257 2941 0 None 1 3 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
44134520 2941 0 None 1 3 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
1152 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
1152 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16129679 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
16129679 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
53395115 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
53395115 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
91898389 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
91898389 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
CHEMBL1981592 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
CHEMBL1981592 3932 13 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
1152 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
1152 3932 13 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
16129679 3932 13 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
53395115 3932 13 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
91898389 3932 13 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
CHEMBL1981592 3932 13 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
1152 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
16129679 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
53395115 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
91898389 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
CHEMBL1981592 3932 13 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
1152 3932 13 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3932 13 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3932 13 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3932 13 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3932 13 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
2276 3293 0 None -316 2 Human 5.5 pKi > 5.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
1155 3516 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16129665 3516 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
3643 3516 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
CHEMBL1201488 3516 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
DB00021 3516 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009